序号 |
标题 |
次数 |
作者 |
发布时间 |
86671 |
DOTA-GnRH的基本介绍 |
114 |
wyh |
2024-11-22 |
86672 |
CAS号:1227407-76-2,叠氮基-单-酰胺-DOTA |
106 |
kx |
2024-11-22 |
86673 |
4-羟基-2-丁炔基-2-羟烷基醚 |
125 |
WYQ |
2024-11-22 |
86674 |
DOTA-MSH ;大环配体-MSH多肽 |
103 |
wyh |
2024-11-22 |
86675 |
WSCS-DOTA-BBN功能化的AuNPs WSCS-DOTA-BBN-AuNPs |
130 |
zcy |
2024-11-22 |
86676 |
3-碘-2-丙炔基-丁基氨基甲酸酯 |
114 |
WYQ |
2024-11-22 |
86677 |
CAS号:272120-41-9,DOTA tribenzyl ester |
88 |
kx |
2024-11-22 |
86678 |
DOTA缀合肽M2pep DOTA-M2pep |
155 |
zcy |
2024-11-22 |
86679 |
CAS号:173308-19-5,DOTAMA(t-BuO)3-en |
97 |
kx |
2024-11-22 |
86680 |
3-(3,3,3-三氟-1-丙炔基)-2,2-二甲基环丙烷羧酸酯 |
102 |
WYQ |
2024-11-22 |
86681 |
DOTA-tris(TBE)-amido dPEG-MAL |
105 |
zyl |
2024-11-22 |
86682 |
1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸 1-(2,5-二氧代-1-吡咯烷基)酯 |
107 |
kx |
2024-11-22 |
86683 |
DOTA-PEG-biotin DOTA-聚乙二醇-生物素 |
95 |
zcy |
2024-11-22 |
86684 |
DOTA-PEG(23)-bromoacetamide*2TFA |
104 |
zyl |
2024-11-22 |
86685 |
CAS号:219143-29-0,DOTA-(MeAm)4 |
104 |
kx |
2024-11-22 |
86686 |
DOTA(tBu3)-PEG(4)-TFP |
100 |
zyl |
2024-11-22 |
86687 |
DOTA-MBP 齐岳定制 |
115 |
zcy |
2024-11-22 |
86688 |
CAS号:293295-66-6,Y-DOTA-TOC |
90 |
kx |
2024-11-22 |
86689 |
CAS:2792156-83-1 IPB-K(DOTA)-FAPI |
97 |
zyl |
2024-11-22 |
86690 |
1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸-Ser-Ser-Ser-LTVSPWY |
110 |
zcy |
2024-11-22 |
86691 |
CAS号:474424-15-2,dota-pnp |
105 |
kx |
2024-11-22 |
86692 |
CU-64 DOTA-TATE |
116 |
zyl |
2024-11-22 |
86693 |
DOTA-hLL2 螯合剂DOTA偶联人源化抗体hLL2 |
119 |
zcy |
2024-11-22 |
86694 |
DOTA-PSMA-EB-01 |
106 |
zyl |
2024-11-22 |
86695 |
1610950-41-8,DOTA-MeTz,DOTA-甲基四嗪 |
105 |
kx |
2024-11-22 |
86696 |
p-NCS-benzyl-DOTA p-NCS-苄基-DOTA |
153 |
zcy |
2024-11-22 |
86697 |
1189194-64-6,DOTA-(COOt-Bu)3-CH2-Alkynyl |
87 |
kx |
2024-11-22 |
86698 |
DOTA-cyclo(RGDfK);DOTA-RGD |
102 |
wyh |
2024-11-22 |
86699 |
CuAAC修饰的DOTAZA 齐岳定制 |
125 |
zcy |
2024-11-22 |
86700 |
1039726-31-2,DOTA-JR-11 |
89 |
kx |
2024-11-22 |
86701 |
zher2-HSA-DOTA DOTA螯合剂偶联ZHER2支架多肽缀合人血清白蛋白 |
134 |
zcy |
2024-11-22 |
86702 |
CAS:1800229-46-2 Maleimide-DOTA-GA |
101 |
zyl |
2024-11-22 |
86703 |
panitumumab-DOTA DOTA标记的抗EGFR帕尼单抗 |
102 |
zcy |
2024-11-22 |
86704 |
DOTA-CH2-Ph-azide(HCl salt) |
97 |
kx |
2024-11-22 |
86705 |
DOTA-三(酸) - 酰氨基-DPEG(R)11-马来酰亚胺 |
114 |
zyl |
2024-11-22 |
86706 |
DOTA-Glu「cyclo(Arg-Gly-Asp-D-Phe-Lys)」2 |
103 |
kx |
2024-11-22 |
86707 |
CAS:834870-39-2 DOTA series |
112 |
zyl |
2024-11-22 |
86708 |
DOTA-cyclo(RGDfK);DOTA-RGD |
105 |
wyh |
2024-11-22 |
86709 |
DOTA-PEG-SH、DOTA-PEG-Thiol的结构组成 |
101 |
kx |
2024-11-22 |
86710 |
DTPA-bis anhydride,二亚乙基三胺五乙酸二酐 |
114 |
wyh |
2024-11-22 |
86711 |
NOTA-PEG5000-Mal ;NOTA PEG5 马来酰亚胺 |
84 |
wyh |
2024-11-22 |
86712 |
DOTA-E「c(RGDfK)2」 |
94 |
kx |
2024-11-22 |
86713 |
DOTA-L-Lys(SA。Pam)-PSMA-617 DOTA偶联二膦酸盐和PSMA抑制剂 |
108 |
zcy |
2024-11-22 |
86714 |
DOTA-E[c(RGDfK)2]的应用领域 |
116 |
kx |
2024-11-22 |
86715 |
DOTA-氟喹诺酮衍生物 DOTA-fluoroquinolone derivatives |
91 |
zcy |
2024-11-22 |